What is the clinical presentation of atrial fibrillation (AFib) with and without right ventricular rupture (RVR)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Atrial fibrillation (AFib) with rapid ventricular response (RVR) typically presents with symptoms including palpitations, shortness of breath, chest discomfort, dizziness, fatigue, and sometimes syncope, whereas AFib without RVR presents with similar irregular rhythm but at a controlled heart rate, resulting in milder or absent symptoms. The clinical presentation of AFib with RVR and without RVR can be distinguished based on the ventricular rate and the resulting symptoms.

  • Symptoms of AFib with RVR include:
    • Palpitations
    • Shortness of breath
    • Chest discomfort
    • Dizziness
    • Fatigue
    • Syncope
  • Physical examination of AFib with RVR reveals an irregularly irregular pulse and variable heart sounds.
  • In contrast, AFib without RVR presents with similar irregular rhythm but at a controlled heart rate, resulting in milder or absent symptoms.
  • Patients with AFib without RVR may be asymptomatic or experience only mild fatigue or reduced exercise tolerance. The difference in presentation stems from the ventricular rate; in AFib with RVR, the AV node conducts many atrial impulses to the ventricles, causing the rapid rate and more severe symptoms, as noted in the guidelines for the management of patients with atrial fibrillation 1. Management of AFib with RVR typically requires immediate rate control with medications like beta-blockers (metoprolol 5-15mg IV), calcium channel blockers (diltiazem 0.25mg/kg IV), or digoxin, followed by consideration of rhythm control strategies, as recommended in the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation 1. AFib without RVR may require less urgent intervention but still warrants assessment for stroke risk and appropriate anticoagulation based on CHA₂DS₂-VASc score, as emphasized in the guidelines for the management of patients with atrial fibrillation 1.

From the Research

Clinical Presentation of Atrial Fibrillation (AF) with Rapid Ventricular Response (RVR)

  • Atrial fibrillation with rapid ventricular response is a common tachyarrhythmia that requires hospitalization due to increased morbidity and mortality from hemodynamic consequences 2.
  • The clinical presentation of AF with RVR can lead to complications such as hypoperfusion and cardiac ischemia, making it essential for emergency physicians to diagnose and manage this condition promptly 3.

Differentiation between Primary and Secondary AF with RVR

  • Differentiating primary and secondary AF with RVR is crucial in the emergency department (ED) assessment and management 3.
  • Evaluating hemodynamic stability is vital in determining the appropriate treatment approach for patients with AF and RVR.

Treatment Approaches for AF with RVR

  • For hemodynamically unstable patients, emergent cardioversion is indicated 3.
  • In hemodynamically stable patients, rate or rhythm control should be pursued, with options including beta blockers or calcium channel blockers for rate control 3, 4, 5, 6.
  • The choice of agent for rate control depends on individual patient factors, clinical situation, and comorbidities, with diltiazem and metoprolol being commonly used options 4, 6.

Comparison of Rate Control Efficacy between Beta-Blockers and Calcium Channel Blockers

  • Studies have compared the efficacy of beta blockers and calcium channel blockers for rate control in patients with AF and RVR, with some findings suggesting that beta blockers may be more effective in rapidly reducing heart rate 5.
  • However, the choice between these two medication classes ultimately depends on individual patient factors and clinical context 5, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of rapid ventricular rate in acute atrial fibrillation.

International journal of clinical pharmacology and therapeutics, 1994

Research

Emergency medicine updates: Atrial fibrillation with rapid ventricular response.

The American journal of emergency medicine, 2023

Research

β-Blockers versus calcium channel blockers for acute rate control of atrial fibrillation with rapid ventricular response: a systematic review.

European journal of emergency medicine : official journal of the European Society for Emergency Medicine, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.